Phase
Condition
Migraine (Pediatric)
Oral Facial Pain
Migraine (Adult)
Treatment
Placebos
Amiloride
Clinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnosis of migraine with aura code
At least 1 aura with aura per month in the 3 months prior to inclusion
No prophylactic antimigraine treatment for at least 1 month prior to inclusion
For women of childbearing age, use of a reliable contraceptive method at least 3months before and 1 month after the study
Signature of written informed consent
Patient affiliated with Social Security
Exclusion
Exclusion Criteria:
Existence of contraindication to taking amiloride:
Known hypersensitivity to the molecule
Hyperkalemia (potassium level (> 5.5 mmol / l))
Use of another hyperkalemic diuretic or potassium salts
Renal insufficiency (clearance <60 ml / min)
Severe hepatocellular insufficiency
In combination with lithium, converting enzyme inhibitors, angiotensin IIinhibitors (except if there is hypokalemia), ciclosporin, tacrolimus,non-antiarrhythmic drugs giving torsades de pointes
Cardiovascular and renal history, for subjects over 75 years old
Patient, who from an investigator's point of view would not be compliant to theprocedure of the study
Pregnant or lactating patient
Patient under trusteeship, under guardianship, protected by law
Study Design
Connect with a study center
Hôpital Pierre Wertheimer
Bron,
FranceSite Not Available
CHU Gabriel Montpied
Clermont-Ferrand,
FranceSite Not Available
AP-HM
Marly,
FranceActive - Recruiting
CHU de Montpellier
Montpellier,
FranceActive - Recruiting
CHU de NICE
Nice,
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.